Navigation Links
Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile
Date:5/9/2008

TAMPA, Fla., May 9 /PRNewswire-USNewswire/ -- Osteoarthritis is a painful and potentially debilitating condition that affects almost 50 million people in the United States. It is caused by deterioration of cartilage in bone joints. The novel investigational pain medication tapentadol, a centrally acting oral analgesic, provided significant relief for patients with joint-disease pain, compared to those treated with placebo, and with fewer gastrointestinal side effects than those treated with an older, prescription pain reliever, researchers announced today.

Results from a Phase 3 clinical study of tapentadol immediate release (IR) tablets showed that patients treated with a 50 mg or 75 mg dose of tapentadol experienced significant relief in end-stage joint disease pain compared to placebo (P<0.001) when assessed over five days of treatment. In addition, patients treated with tapentadol experienced significantly better digestive tract tolerability compared to patients treated with 10 mg of oxycodone IR. Digestive tract tolerability is one of the leading causes of treatment discontinuation for patients who take prescription pain medications.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) presented these new data in a poster session at the 27th Annual Scientific Meeting of the American Pain Society (APS) in Tampa, Florida.

Tapentadol has a unique profile with two mechanisms of action, combining mu-opioid receptor agonism and norepinephrine reuptake inhibition in a single molecule. It is being developed in immediate-release formulation for acute pain and extended-release formulation for chronic pain.

Mu-opioid agonists are drugs that bind to and activate mu-opioid receptors in the central nervous system. These drugs modify sensory and affective (mood) aspects of pain, inhibit the transmission of pain at the spinal cord and affect activity at parts of the brain that control how pain is perceived. Nor
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...wire/ -- ,, Beverage Can Stay-Tabs Pose Swall...dren,s Hospital Medical Center reports that bevera...In the 1970s, U.S. manufacturers switched to the s...bs. The new study found 19 cases of stay-tab inges...rs. Further, the study found that most ingested st...
(Date:11/29/2009)... large proportion of patients who undergo abdomina...ted and unnecessary additional image acquisition r...according to a study presented today at the annual...ica (RSNA). ,, "It is the responsibility of all...sure that the dosage is as low as reasonably achie...
(Date:11/29/2009)...UJIFILM Medical Systems USA, Inc. is pleased to un...DR cassette, at the 2009 Radiological Society of N... clinical environment, FDR D-EVO uses an innovativ...lm,s trademark image quality and outstanding flexi...transition to DR without modification to the exam ...
Breaking Medicine Technology:Monday, Nov. 30: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Monday, Nov. 30: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 2Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 3FUJIFILM's DR Cassette Makes World Debut 2Premier Research Strengthens their Medical Affairs and Strategic Consulting Group with New Appointments 56555 1Premier Research Strengthens their Medical Affairs and Strategic Consulting Group with New Appointments 56555 2SyntheMed Receives Brazilian Regulatory Approval for REPEL CV 28TM 29 13937 1SyntheMed Receives Brazilian Regulatory Approval for REPEL CV 28TM 29 13937 2Emdeon Receives EHNAC Healthcare Network Re accreditation 56549 1Emdeon Receives EHNAC Healthcare Network Re accreditation 56549 2Emdeon Receives EHNAC Healthcare Network Re accreditation 56549 3
...SINESS WIRE)--Mar 7, 2007 - Gemin X,announced toda...,the journal Blood demonstrated that its lead comp...ic responses against,patient-derived multiple myel...ti-myeloma effects when used as a combination ther...igned to inhibit all,relevant members of the Bcl-2...
...tudy in Inoperable Chronic,Thromboembolic Pulmonar...Pulmonary Vascular Resistance Met - Six-Minute-wal...Score and,Biological Disease Marker , , ALLSCHWI...ATLN) announced today the initial results from the...dy BENEFiT (Bosentan Effects in,Inoperable Forms o...
Other Medicine Technology:Gemin X Announces Publication of Preclinical Data of GX15-070 in,Multiple Myeloma in Blood 2Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 2Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 3Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 4Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 5Actelion Announces Positive Study with Bosentan (Tracleer) in,CTEPH 6
(Date:11/30/2009)...UT Southwestern Medical Center researchers have fo...ff complications associated with asthma. The findi... Pediatrics, suggest that interventions by paren...ve received specialized topical training can effe... room visits and missed adult workdays. , "Child...
(Date:11/29/2009)...he Academy of General Dentistry (AGD) announces th... the Mastership Award during the AGD,s commencemen...ent to excellence in dental education.,To accompl...oved continuing dental education in the 16 discipl...o hands-on skills and techniques. , ...
(Date:11/29/2009)...ed for something leads to more self-defensive fing.... 29 (HealthDay News) -- The blame game is a conta...et is innocent. , Researchers found that when p..., even if it,s an unfair accusation, they,re much ..., "When we see others protecting their egos, we be...
(Date:11/29/2009)...raditional healthcare,s uncertain future and risin...ative care. Affordable Acupuncture Scottsdale answ...ovember 29, 2009 -- Affordable Acupuncture, LLC op... has been met with enthusiasm and gratitude. Its i...ibuted to two things, need and cost. "As far...
(Date:11/28/2009)...believed to affect circadian rhythm, , ...arch suggests that an internal body clock that goe...t of bipolar disorder in children. , The findi...eup of 152 children with bipolar disorder, which c...nd 140 children without the disorder. They linked ...
Breaking Medicine News(10 mins):Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:When Accusations Start to Fly, They Multiply 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Bipolar Disorder May Be Tied to Body Clock 2
...e testing needed to prove that oversulfated chondr..., WEDNESDAY, April 23 (HealthDay News) -- U.S. res...ood thinner heparin pulled from the market are con... , And, according to a paper published online simu...
...HINGTON, April 23 Speaker Nancy Pelosi,spoke at t...l Rotunda this,morning honoring renowned heart sur...remarks:, "Good morning. It is a special honor in...ue Representative Al,Green, and others who worked ...
...cent Per Pack Increase Would Help Raise $390 Milli...o leaders should,fund a proposed economic stimulus... raiding tobacco prevention funds, recommends a re...es and,save money by reducing health care costs, w...
...TOR, Ohio, April 23 STERIS Corporation,(NYSE: ST...s authorized a,regular quarterly dividend in the a...ayable June 11, 2008 to shareholders of record at ...nowledgeable people and innovative infection,preve...
...WORCESTER, Mass.The Elizabeth Glaser Pediatric AID...against pediatric AIDS, announced that it will awa...to support the development of a pediatric HIV vacc...MD, professor of pediatrics and director of the di...
...BOSTON, April 23 I Lost It at the Club!, a,fitnes...ve coordinated by,the International Health, Racque...y Michael Foods, AllWhites(R), helped a total of 2... at,the Club!, which ran for eight weeks from Janu...
Other Medicine News:Health News:Researchers Identify Contaminant in Tainted Heparin 2Health News:Researchers Identify Contaminant in Tainted Heparin 3Health News:Pelosi: 'By Literally Fixing Broken Hearts, Dr. DeBakey Has Given Hope and Health to Millions' 2Health News:New Report: Increasing Ohio's Tobacco Tax Would Fund Economic Stimulus Plan and Preserve Highly-Successful Tobacco Prevention Program 2Health News:New Report: Increasing Ohio's Tobacco Tax Would Fund Economic Stimulus Plan and Preserve Highly-Successful Tobacco Prevention Program 3Health News:New Report: Increasing Ohio's Tobacco Tax Would Fund Economic Stimulus Plan and Preserve Highly-Successful Tobacco Prevention Program 4Health News:STERIS Corporation Declares Regular Quarterly Dividend 2Health News:STERIS Corporation Declares Regular Quarterly Dividend 3Health News:UMass Medical School researchers awarded pediatric HIV vaccine development grant 2Health News:UMass Medical School researchers awarded pediatric HIV vaccine development grant 3Health News:U.S. Health Club Members Proclaim - 'I Lost It at the Club!' and Lose 45 Tons of Excess Weight 2Health News:U.S. Health Club Members Proclaim - 'I Lost It at the Club!' and Lose 45 Tons of Excess Weight 3Health News:U.S. Health Club Members Proclaim - 'I Lost It at the Club!' and Lose 45 Tons of Excess Weight 4
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...
Medicine Products: